| Assessment Status | Rapid Review complete |
| HTA ID | - |
| Drug | Bilastine |
| Brand | Drynol® |
| Indication | Symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria. |
| Assessment Process | |
| Rapid review commissioned | 10/03/2011 |
| Rapid review completed | 23/03/2011 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended. |